Scilex Holding Company

NasdaqCM:SCLX Stock Report

Market Cap: US$67.1m

Scilex Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:SCLX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Dec 24BuyUS$13,800Jaisim ShahIndividual30,000US$0.46
31 Oct 24BuyUS$8,351Henry JiIndividual8,888US$0.94
29 Oct 24BuyUS$31,670Jaisim ShahIndividual32,000US$0.99
18 Oct 24BuyUS$4,750Jay ChunIndividual5,000US$0.95
18 Oct 24BuyUS$990Dorman FollowwillIndividual1,000US$0.99
17 Oct 24BuyUS$1,800David LemusIndividual2,000US$0.90
17 Oct 24BuyUS$18,992Yue WuIndividual20,000US$0.95
17 Oct 24BuyUS$9,710BioVintage incCompany10,000US$0.97
16 Oct 24BuyUS$6,499Stephen MaIndividual6,700US$0.97
16 Oct 24BuyUS$29,751Jaisim ShahIndividual30,000US$0.99
17 May 24BuyUS$43,985BioVintage incCompany50,000US$0.88
17 May 24BuyUS$12,443Stephen MaIndividual14,140US$0.88
17 May 24BuyUS$121,945Jaisim ShahIndividual140,000US$0.92
17 May 24BuyUS$51,641Jay ChunIndividual57,500US$0.90

Insider Trading Volume

Insider Buying: SCLX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SCLX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,079,3400.589%
Public Companies10,917,2105.96%
Institutions34,447,25518.8%
Private Companies51,099,28427.9%
General Public85,701,21146.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 84%.

Top Shareholders

Top 25 shareholders own 52.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.9%
Sclx Stock Acquisition Jv Llc
51,039,214US$18.7m-15%no data
4.91%
Oramed Pharmaceuticals Inc.
9,000,000US$3.3m0%no data
4.08%
State Street Global Advisors, Inc.
7,484,310US$2.7m0.73%no data
3.66%
BlackRock, Inc.
6,707,701US$2.5m0%no data
3.3%
The Vanguard Group, Inc.
6,038,211US$2.2m13.1%no data
1.92%
Armistice Capital LLC
3,510,000US$1.3m-70.6%0.03%
1.05%
Sorrento Therapeutics, Inc.
1,917,210US$702.5k0%no data
0.8%
Millennium Management LLC
1,461,034US$535.3k466%no data
0.71%
Geode Capital Management, LLC
1,295,330US$474.6k0.51%no data
0.42%
Northern Trust Global Investments
776,786US$284.6k-0.24%no data
0.34%
D. E. Shaw & Co., L.P.
627,038US$229.7k0%no data
0.34%
Rafferty Asset Management, LLC
620,131US$227.2k0%no data
0.34%
Henry Ji
618,065US$226.5k1.46%no data
0.33%
Citadel Advisors LLC
596,152US$218.4k276%no data
0.31%
Citigroup Inc.,Banking and Securities Investments
562,706US$206.2k577%no data
0.29%
Janus Henderson Group plc
534,302US$195.8k3.46%no data
0.26%
Norges Bank Investment Management
477,619US$175.0k0%no data
0.22%
JP Morgan Asset Management
397,660US$145.7k0%no data
0.16%
Jaisim Shah
295,215US$108.2k45.3%no data
0.14%
Squarepoint OPS LLC
265,002US$97.1k588%no data
0.14%
RA Capital Management, L.P.
261,179US$95.7k0%no data
0.13%
Heights Capital Management, Inc.
233,463US$85.5k9.82%0.01%
0.12%
LMR Partners LLP
213,368US$78.2k1.59%no data
0.11%
Barclays PLC Private Banking & Investment Banking Investment
195,465US$71.6k0%no data
0.1%
Morgan Stanley, Investment Banking and Brokerage Investments
186,623US$68.4k2.22%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 07:00
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Scilex Holding Company is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Mayank MamtaniB. Riley Securities, Inc.
Raghuram SelvarajuH.C. Wainwright & Co.